Advanced pancreatic cancer: the standard of care and new opportunities

Main Article Content

Amrallah A. Mohammad *
(*) Corresponding Author:
Amrallah A. Mohammad | amrallaabdelmoneem@yahoo.com

Abstract

Presentation of pancreatic cancer is localized, locally advanced or metastatic. With the later represented the main bulk (more than 80%). Despite the significant innovation in molecular analysis and therapeutic approach in many types of cancer in the last two decades, still the outcome of advanced pancreatic cancer is disappointing and the mortality rate approximately unchanged. In this mandated review we intended to highlight the standard of care and emerging agents for advanced pancreatic cancer treatment.


Downloads month by month

Downloads

Download data is not yet available.

Article Details